WuXi Biologics to divest Irish vaccine facility to Merck amid US legislative pressures - PRESS AI WORLD
PRESSAI
Recent Posts
side-post-image
side-post-image
Economy

WuXi Biologics to divest Irish vaccine facility to Merck amid US legislative pressures

share-iconTuesday, January 07 comment-icon2 weeks ago 9 views
News sources:
scmpSCMP
WuXi Biologics to divest Irish vaccine facility to Merck amid US legislative pressures

Credited from: SCMP

  • WuXi Biologics is set to sell its Irish vaccine facility to Merck & Co for approximately US$500 million.
  • This move occurs in anticipation of looming US legislation that may restrict business for Chinese biotech firms.
  • The Biosecure Act, passed by the US House, specifically names WuXi as a targeted company.
  • Analysts suggest WuXi may be looking to adjust operations due to increased scrutiny from the US government.
  • This sale follows other reports of WuXi planning to divest some operations in light of political tensions.

Read more on the original article: South China Morning Post.

SHARE THIS ARTICLE:

nav-post-picture
nav-post-picture